Tumour-specific vector for gene therapy

Details Tumour-specific vector for gene therapy Tumour-specific vector for gene therapy

2005-08-30

2005-08-30

Priebe, Scott D. (Department: 1632)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C424S093200, C435S320100, C435S455000, C435S456000

Reexamination Certificate

active

06936595

ABSTRACT:
The invention relates to a vector for the gene therapeutic treatment of tumours, especially in connection with radiotherapy. Said vector is provided with a therapeutic gene in the DNA sequence thereof. The gene is controlled by the promoter for the catalytic subunit of the telomerase or by the promoter for cyclin A.

REFERENCES:
patent: 5457035 (1995-10-01), Baum et al.
patent: 5856153 (1999-01-01), Tiraby et al.
patent: 4444949 (1998-11-01), None
patent: 19751587 (1999-07-01), None
patent: 19757984 (1999-07-01), None
patent: WO 96/18737 (1996-06-01), None
patent: WO 98/11207 (1998-03-01), None
patent: WO 98/35028 (1998-08-01), None
patent: WO 99/33998 (1999-07-01), None
patent: WO 99/38992 (1999-08-01), None
patent: WO 99/60142 (1999-11-01), None
patent: WO 00/46355 (2000-08-01), None
patent: WO 00/56909 (2000-09-01), None
Majumdar et al., HSV TK “suicide” gene therapy using human telomerase reverse transcriptase (hTERT) promoter, Proc. Amer. Assoc. Cancer Res. Ann. Meeting 41: 379, #2406, Mar. 2000.
Freytag et al., “A novel three-pronged approach to kill cancer cells selectively,” Human Gene Ther. 9: 1323-1333, Jun. 10, 1998.
Uckert, W., et al. (1998) Double Suicide Gene (Cytosine Deaminase and Herpes Simplex Virus Thymidine Kinase) but Not Single Gene Transfer Allows Reliable Elimination of Tumor Cells in Vivo. Human Gene Therapy 9:855-885.
Ali, M., et al. (1994) The use of DNA viruses as vectors for gene therapy. Gene Therapy 1:387-384.
Rothmann, T., et al. (1998) Replication of ONYX-015, a Potential Anticancer Adenovirus, Is Independent of p53 Status in Tumor Cells. J. Virol. 72(12):9470-9478.
Heise, C., et al. (1997) ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nature Medicine 3(6):639-645.
Henglein, B., et al. (1994) Structure and cell cycle-regulated transcription of the human cyclin A gene. PNAS 91:5490-5494.
Horikawa, I., et al. (1999) Cloning and Characterization of the Promoter Region ofHuman Telomerase Reverse TranscriptaseGene. Cancer Research 59:826-830.
Takakura, M., et al. (1999) Cloning of Human Telomerase Catalytic Subunit (hTERT) Gene Promoter and Identification of Proximal Core Promoter Sequences Essential for Transcriptional Activation in Immortalized and Cancer Cells. Cancer Research 59:551-557.
Joki, T., et al. (1995) Activation of the Radiosensitive EGR-1 Promoter Induces Expression of the Herpes Simplex Virus Thymidine Kinase Gene and Sensitivity of Human Glioma Cells to Ganciclovir. Human Gene Therapy 8:1507-1513.
Koga, S., et al. (2000) A Novel Telomerase-Specific Gene Therapy: Gene Transfer of Caspase-8 Utilizing the Human Telomerase Catalytic Subunit Gene Promoter. Human Gene Therapy 11:1397-1406.
Nettelbeck, D. M., et al. (1998) Cell Cycle Regulated Promoters for the Targeting of Tumor Endothelium. Adv. Exp. Med. Biol. 451:437-440.
Nettelbeck, D. M., et al. (2000) Gene therapy designer promoters for tumour targeting. Trends in Genetics 16(4):174-181.
Pan, C.-X and Koeneman, K. S. (1999) A novel tumor-specific gene therapy for bladder cancer. Medical Hypotheses. 53(2):130-135.
Tomanin, R., et al. (1997) Development and characterization of a binary gene expression system base on bacteriophage T7 components in adenovirus vectors. Gene 193:129-140.

Affiliated with

Also associated with

Rating

Tumour-specific vector for gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumour-specific vector for gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumour-specific vector for gene therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3523414